The Latest Breaking News from HHS

Stock futures lower as Fed decision looms, earnings in focus; Samsung confirms weakest quarterly profit in eight years, maintains capex plans; UnitedHealth, Humana slide as Medicare plans overpayment clawback; Exxon earnings on deck after Chevron miss and AMD earnings in focus as chip sector feels global demand slump.

A key member of Biden's COVID team is retiring, and there's no new federal funding.

While antiviral pills are plentiful and remain an option for some with weak immune systems, they won’t work for everyone — Pfizer’s Paxlovid interacts with many widely prescribed drugs.

Made public here for the first time, a collection of key internal government documents related to the Trump administration’s Zero Tolerance policy

Nearly 6 million Americans have taken Paxlovid for free, courtesy of the federal government. The Pfizer pill has helped prevent many people infected with COVID-19 from being hospitalized or dying, and it may even reduce the risk of developing long COVID. But the government plans to stop footing the bill…

What happens if the COVID national emergency ends

Within months, the government plans to stop footing the bill — and millions of the uninsured and seniors might have to pay full price. Experts say that means fewer people will get the potentially life-saving treatments.

The Biden administration is actively searching for ways to safeguard abortion access for millions of women

With new infections down, health officials will wind down emergency and let it expire by end of next month.